In individuals with mild (creatinine clearance 50 - 80 ml/ min), moderate (creatinine clearance 30 - 49 ml/ min) and severe (creatinine clearance 15 - 29 ml/ min) renal impairment, rivaroxaban plasma concentrations (AUC) were increased 1.4, 1.5 and 1.6 fold respectively.